Abbott Laboratories (ABT)
NYSE: ABT · Real-Time Price · USD
102.87
+0.49 (0.48%)
At close: Apr 2, 2026, 4:00 PM EDT
103.56
+0.69 (0.67%)
After-hours: Apr 2, 2026, 7:53 PM EDT

Abbott Laboratories Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter
Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021Q2 2021Q1 2021
Period Ending
Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21 Jun '21 Mar '21
11,45911,36911,14210,35810,97410,63510,3779,96410,24110,1439,9789,74710,09110,41011,25711,89511,46810,92810,22310,456
Revenue Growth (YoY)
4.42%6.90%7.37%3.95%7.16%4.85%4.00%2.23%1.49%-2.56%-11.36%-18.06%-12.01%-4.74%10.11%13.76%7.17%23.44%39.51%35.34%
Cost of Revenue
4,9225,0754,8544,4684,9424,6984,6034,4634,5564,6054,4834,3314,5934,6294,9334,9874,7664,4234,9474,401
Gross Profit
6,5376,2946,2885,8906,0325,9375,7745,5015,6855,5385,4955,4165,4985,7816,3246,9086,7026,5055,2766,055
Selling, General & Admin
3,1293,0513,0913,0612,9072,8952,9362,9592,7242,7232,7402,7622,9732,7312,7572,7873,0482,7672,7262,783
Depreciation & Amortization Expenses
422420420420465470471472481496498491496498507512514520504509
Research & Development
735766725716749713698684700672715654725782684697762672654654
Total Operating Expenses
4,2864,2374,2364,1974,1214,0784,1054,1153,9053,8913,9533,9074,1944,0113,9483,9964,3243,9593,8843,946
Operating Income
2,2512,0572,0521,6931,9111,8591,6691,3861,7801,6471,5421,5091,3041,7702,3762,9122,3782,5461,3922,109
Interest Income
-777182-918280-9798101-552614-101111
Interest Expense
-162-121-121-131-181-142-140-141-229-166-159-153-220-141-132-131-251-133-134-135
Other Non-Operating Income (Expense)
149167148134164132-411185931551058274828169707958
Total Non-Operating Income (Expense)
-131239885-1781-6250-144249453-138-12-24-36-182-53-44-66
Pretax Income
2,3582,1802,1501,7782,0301,9401,6071,4361,7951,6711,6361,5621,3201,7582,3522,8762,3272,4931,3482,043
Provision for Income Taxes
582536371453-7,199294305211201235261244287323334429338393159250
Net Income
1,7761,6441,7791,3259,2291,6461,3021,2251,5941,4361,3751,3181,0331,4352,0182,4471,9892,1001,1891,793
Net Income to Common
1,7761,6441,7791,3259,2291,6461,3021,2251,5941,4361,3751,3181,0331,4352,0182,4471,9892,1001,1891,793
Net Income Growth
-80.76%-0.12%36.64%8.16%478.98%14.62%-5.31%-7.06%54.31%0.07%-31.86%-46.14%-48.06%-31.67%69.72%36.48%-8.00%70.45%121.42%217.91%
Shares Outstanding (Basic)
1,7471,7421,7431,7391,7461,7391,7431,7401,7481,7391,7401,7421,7511,7531,7541,7621,7681,7751,7791,777
Shares Outstanding (Diluted)
1,7471,7491,7511,7471,7461,7481,7511,7501,7481,7481,7501,7521,7661,7641,7651,7751,7841,7891,7931,792
Shares Change (YoY)
0.06%0.10%-0.02%-0.14%-0.11%-0.04%0.05%-0.12%-1.02%-0.87%-0.86%-1.29%-1.00%-1.42%-1.55%-0.95%-0.29%0.06%0.46%0.61%
EPS (Basic)
1.010.941.020.765.270.940.740.700.910.820.790.750.510.821.151.381.111.180.671.00
EPS (Diluted)
1.010.941.010.765.270.940.740.700.910.820.780.750.510.811.141.371.111.170.661.00
EPS Growth
-80.84%-36.49%8.57%479.12%14.63%-5.13%-6.67%78.43%1.23%-31.58%-45.26%-54.05%-30.77%72.73%37.00%-7.50%69.56%120.00%222.58%
Shares Outstanding
1,7371,7391,7401,7401,7321,7341,7401,7401,7341,7361,7351,7391,7381,7441,7511,7511,7641,7681,7731,777
Free Cash Flow
2,6262,2911,5459332,1482,1491,4276272,2831,3176967631,7162,3132,0311,7442,4532,2401,7152,240
Free Cash Flow Growth
22.25%6.61%8.27%48.80%-5.91%63.17%105.03%-17.82%33.04%-43.06%-65.73%-56.25%-30.04%3.26%18.43%-22.14%-21.35%42.68%152.21%530.99%
Free Cash Flow Per Share
1.501.310.880.531.231.230.810.361.310.750.400.440.971.311.150.981.381.250.961.25
Dividends Per Share
0.6300.5900.5900.5900.5900.5500.5500.5500.5500.5100.5100.5100.5100.4700.4700.4700.4700.4500.4500.450
Dividend Growth
6.78%7.27%7.27%7.27%7.27%7.84%7.84%7.84%7.84%8.51%8.51%8.51%8.51%4.44%4.44%4.44%4.44%25.00%25.00%25.00%
Gross Margin
57.05%55.36%56.44%56.86%54.97%55.83%55.64%55.21%55.51%54.60%55.07%55.57%54.48%55.53%56.18%58.07%58.44%59.53%51.61%57.91%
Operating Margin
19.64%18.09%18.42%16.34%17.41%17.48%16.08%13.91%17.38%16.24%15.45%15.48%12.92%17.00%21.11%24.48%20.74%23.30%13.62%20.17%
Profit Margin
15.50%14.46%15.97%12.79%84.10%15.48%12.55%12.29%15.56%14.16%13.78%13.52%10.24%13.78%17.93%20.57%17.34%19.22%11.63%17.15%
FCF Margin
22.92%20.15%13.87%9.01%19.57%20.21%13.75%6.29%22.29%12.98%6.98%7.83%17.01%22.22%18.04%14.66%21.39%20.50%16.78%21.42%
EBITDA
3,0432,8482,8292,4492,7182,6602,4742,1912,5932,4712,3422,3152,1112,5853,1983,7353,2613,3932,2663,043
EBITDA Margin
26.56%25.05%25.39%23.64%24.77%25.01%23.84%21.99%25.32%24.36%23.47%23.75%20.92%24.83%28.41%31.40%28.44%31.05%22.17%29.10%
EBIT
2,2512,0572,0521,6931,9111,8591,6691,3861,7801,6471,5421,5091,3041,7702,3762,9122,3782,5461,3922,109
EBIT Margin
19.64%18.09%18.42%16.34%17.41%17.48%16.08%13.91%17.38%16.24%15.45%15.48%12.92%17.00%21.11%24.48%20.74%23.30%13.62%20.17%
Effective Tax Rate
24.68%24.59%17.26%25.48%-354.63%15.15%18.98%14.69%11.20%14.06%15.95%15.62%21.74%18.37%14.20%14.92%14.53%15.76%11.80%12.24%
Updated Jan 22, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q